Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Opgen Inc (OPGN)

Opgen Inc (OPGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Navigating the Roller Coaster of Recent Penny Stock Surges

Recent surges in penny stocks, like Secoo (SECO), Tempest Therapeutics (TPST), and OpGen (OPGN), have fueled speculation and excitement in penny stocks.

SECO : 0.3699 (-10.74%)
OPGN : 0.5889 (-3.93%)
TPST : 3.52 (+2.92%)
Zacks.com featured highlights include Disney, Casey's General Stores, OpGen, Accelerate Diagnostics and Nektar Therapeutics

Disney, Casey's General Stores, OpGen, Accelerate Diagnostics and Nektar Therapeutics are part of the Zacks Screen of the Week article.

DIS : 113.47 (-0.21%)
NKTR : 1.4100 (-0.70%)
CASY : 315.29 (+0.63%)
AXDX : 0.9030 (-4.95%)
OPGN : 0.5889 (-3.93%)
Forget Bargain Hunting, Buy 5 Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Disney (DIS), Casey's General Stores (CASY), OpGen (OPGN), Accelerate Diagnostics (AXDX) and Nektar...

DIS : 113.47 (-0.21%)
NKTR : 1.4100 (-0.70%)
CASY : 315.29 (+0.63%)
AXDX : 0.9030 (-4.95%)
OPGN : 0.5889 (-3.93%)
OpGen (NASDAQ: OPGN) Reports Positive Data from Clinical Trial for Unyvero as Diagnostic for UTI

OpGen, Inc. (NASDAQ: OPGN) is engaged as a precision medicine company that is focused on developing molecular diagnostics and bioinformatics

OPGN : 0.5889 (-3.93%)
Alignment Healthcare (ALHC) Reports Q2 Loss, Tops Revenue Estimates

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 76.92% and 8.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ALHC : 5.23 (+0.97%)
OPGN : 0.5889 (-3.93%)
LHC Group (LHCG) Lags Q2 Earnings and Revenue Estimates

LHC (LHCG) delivered earnings and revenue surprises of -25.76% and 3.80%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

LHCG : 169.81 (+0.47%)
OPGN : 0.5889 (-3.93%)
OpGen to Provide Business Update and Financial Results for the Second Quarter 2022 on August 11th at 4:30 p.m. Eastern Time

ROCKVILLE, Md., July 28, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a...

OPGN : 0.5889 (-3.93%)
OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven

Collaborators aim to develop and evaluate computation tools, including predictive models for whole genome sequencing-based antibiotic susceptibility...

OPGN : 0.5889 (-3.93%)
OpGen Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2022 and Provides Business Update

Preliminary Total Revenue for Q2 2022 was approximately $1.0 millionCash as of June 30, 2022 was approximately $16.6 millionFirst commercial customer...

OPGN : 0.5889 (-3.93%)
OpGen Announces Publication of Results of Unyvero Hospitalized Pneumonia (HPN) Panel for Detection of Bacterial Respiratory Tract Pathogens from Serial Specimens Collected from Hospitalized COVID-19 Patients

Results were published in the European Journal of Clinical Microbiology & Infectious Diseases Serial specimen analysis confirms correct detection of...

OPGN : 0.5889 (-3.93%)

Barchart Exclusives

Unusual Call Options Activity in Palantir Technologies Stock Highlights Its Value
Today a large volume of out-of-the-money (OTM) call options for Palantir Technologies stock has traded in a near-term expiry period. This highlights the underlying value of this AI and software security company. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar